Filter
939
Filtered Results: 939
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
79
New Publications
285
Language
Document type
No document type
483
Studies & Reports
170
Guidelines
141
Manuals
57
Strategic & Response Plan
52
Fact sheets
15
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
41
Ethiopia
37
India
32
Uganda
27
South Africa
24
Global
23
Liberia
21
Ghana
20
Nigeria
19
Rwanda
18
Tanzania
17
Sierra Leone
16
Zambia
16
Malawi
15
Bangladesh
15
Nepal
14
Western and Central Europe
14
Namibia
13
Ukraine
11
Zimbabwe
10
Syria
9
Africa
9
Cambodia
9
Myanmar / Burma
9
Lesotho
8
Philippines
8
Eastern Europe
8
Botswana
8
South–East Asia Region
6
West and Central Africa
5
Indonesia
5
Eswatini/ Swaziland
5
Latin America and the Carribbean
4
Congo, Democratic Republic of
4
Western Pacific Region
4
East and Southern Africa
4
Thailand
3
Benin
3
Albania
3
Burkina Faso
3
Guinea
3
Jordan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Pakistan
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
USA
2
Haiti
2
Asia
2
United Kingdom
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Germany
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
415
Clinical Guidelines
58
Key Resources
36
Public Health
35
Pharmacy & Technologies
28
Women & Child Health
23
Capacity Building
3
Toolboxes
AMR
123
Pharmacy
118
COVID-19
54
HIV
39
TB
39
Rapid Response
34
Mental Health
31
Global Health Education
20
Planetary Health
19
Caregiver
14
NTDs
14
Conflict
14
Ebola & Marburg
13
Health Financing Toolbox
13
Specific Hazards
10
NCDs
10
Polio
5
Refugee
2
Natural Hazards
2
Disability
2
Zika
2
Social Ethics
1
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
This document has been developed as a guide to allinstitutions producing health care waste in planning and implementation of interventions that will reduce mismanagement of hazardous waste in Zambia.The National Health-Care Waste Management Plan for 2015 to 2019 provides an overv...
Interim policy guidance
The National Action Plan (NAP) has been developed based on the model recommended in the global Action Plan. Local data on on-going interventions were collected from technical informants in the various areas of work. These were analysed using the policy framework provided by the AMR policy document. ...
Two test methods on dexamethasone tablets and injections
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The ethical governance of research assumes the existence of a national entity (or subnational if applicable, according to the constitution of a country) in charge of supervising the research ethics committees (RECs) that review and monitor research with human beings. This supervision includes the ac...
WHO Secretariat Information paper July 2016
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, community care centres, Ebola treatment centres and isolation centres. The Governments of Guinea, Liberia an...
WHO Vaccine Management Handbook
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
